LV10917B - New use of bambuterol - Google Patents

New use of bambuterol Download PDF

Info

Publication number
LV10917B
LV10917B LVP-93-816A LV930816A LV10917B LV 10917 B LV10917 B LV 10917B LV 930816 A LV930816 A LV 930816A LV 10917 B LV10917 B LV 10917B
Authority
LV
Latvia
Prior art keywords
bambuterine
lipid
lowering
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
LVP-93-816A
Other languages
English (en)
Latvian (lv)
Other versions
LV10917A (lv
Inventor
Bauer Carl-Axel
Svensson Leif-Ake
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of LV10917A publication Critical patent/LV10917A/xx
Publication of LV10917B publication Critical patent/LV10917B/lv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
LVP-93-816A 1990-03-16 1993-06-30 New use of bambuterol LV10917B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9000948A SE9000948D0 (sv) 1990-03-16 1990-03-16 New use
PCT/SE1991/000195 WO1991013615A1 (en) 1990-03-16 1991-03-14 New use of bambuterol

Publications (2)

Publication Number Publication Date
LV10917A LV10917A (lv) 1995-12-20
LV10917B true LV10917B (en) 1996-04-20

Family

ID=20378886

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-816A LV10917B (en) 1990-03-16 1993-06-30 New use of bambuterol

Country Status (28)

Country Link
US (2) US5837727A (cs)
EP (1) EP0521967B1 (cs)
JP (1) JP3081640B2 (cs)
KR (1) KR100194995B1 (cs)
AT (1) ATE138570T1 (cs)
AU (1) AU653149B2 (cs)
CA (1) CA2077762C (cs)
CZ (1) CZ279308B6 (cs)
DE (1) DE69119896T2 (cs)
DK (1) DK0521967T3 (cs)
EG (1) EG19645A (cs)
ES (1) ES2087291T3 (cs)
GR (1) GR3020700T3 (cs)
HK (1) HK52197A (cs)
HU (1) HU211998B (cs)
IE (1) IE80668B1 (cs)
IL (1) IL97509A (cs)
LT (1) LT3734B (cs)
LV (1) LV10917B (cs)
MY (1) MY114218A (cs)
NZ (1) NZ237279A (cs)
PT (1) PT97052B (cs)
RU (1) RU2093153C1 (cs)
SE (1) SE9000948D0 (cs)
SG (1) SG64895A1 (cs)
SK (1) SK278815B6 (cs)
WO (1) WO1991013615A1 (cs)
ZA (1) ZA911452B (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9000948D0 (sv) * 1990-03-16 1990-03-16 Draco Ab New use
US6459316B1 (en) * 2000-12-08 2002-10-01 Intel Corporation Flip flop circuit
KR20040068240A (ko) * 2001-12-14 2004-07-30 노보 노르디스크 에이/에스 호르몬 민감성 리파아제의 활성을 감소시키기 위한 화합물및 그들의 사용
US7495028B2 (en) 2002-08-08 2009-02-24 Wen Tan R-bambuterol, its preparation and therapeutic uses
WO2004014290A2 (en) * 2002-08-08 2004-02-19 Cheng J L R-bambuterol, its preparation and therapeutic uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3163871D1 (en) * 1980-07-09 1984-07-05 Draco Ab 1-(dihydroxyphenyl)-2-amino-ethanol derivatives; preparation, compositions and intermediates
US4472436A (en) * 1982-12-06 1984-09-18 Neo-Bionics, Inc. Increasing HDL-cholesterol levels with phenylethylamine derivatives
EP0244062A3 (en) * 1986-03-03 1990-06-20 Beecham Group Plc Use of aryl ethanol amine derivatives in the treatment of atherosclerosis
SE9000948D0 (sv) * 1990-03-16 1990-03-16 Draco Ab New use

Also Published As

Publication number Publication date
GR3020700T3 (en) 1996-10-31
EG19645A (en) 1995-09-30
IE80668B1 (en) 1998-11-18
CA2077762A1 (en) 1991-09-17
HK52197A (en) 1997-05-02
HUT61461A (en) 1993-01-28
ATE138570T1 (de) 1996-06-15
SG64895A1 (en) 2000-01-25
CZ279308B6 (cs) 1995-04-12
DE69119896D1 (de) 1996-07-04
IL97509A (en) 1995-12-31
IL97509A0 (en) 1992-06-21
IE910862A1 (en) 1991-09-25
PT97052B (pt) 1998-07-31
SE9000948D0 (sv) 1990-03-16
AU7569191A (en) 1991-10-10
DE69119896T2 (de) 1996-10-10
CS9100681A2 (en) 1991-10-15
JP3081640B2 (ja) 2000-08-28
PT97052A (pt) 1991-10-31
SK278815B6 (sk) 1998-03-04
HU211998B (en) 1996-01-29
DK0521967T3 (da) 1996-09-09
US6034123A (en) 2000-03-07
JPH05504971A (ja) 1993-07-29
EP0521967B1 (en) 1996-05-29
NZ237279A (en) 1993-08-26
MY114218A (en) 2002-09-30
CA2077762C (en) 2001-06-12
ES2087291T3 (es) 1996-07-16
AU653149B2 (en) 1994-09-22
ZA911452B (en) 1991-11-27
LV10917A (lv) 1995-12-20
RU2093153C1 (ru) 1997-10-20
KR100194995B1 (ko) 1999-06-15
LT3734B (en) 1996-02-26
HU9202958D0 (en) 1992-12-28
LTIP1735A (en) 1995-07-25
WO1991013615A1 (en) 1991-09-19
US5837727A (en) 1998-11-17
EP0521967A1 (en) 1993-01-13

Similar Documents

Publication Publication Date Title
AU2000249434B2 (en) Stabilized pharmaceutically effective composition and pharmaceutical formulation comprising the same
JP2002532409A (ja) ＨＭＧ−ＣｏＡレダクターゼインヒビターを含む安定な薬学的処方物
PL323487A1 (en) Three-phase pharmaceutic form of constant-rate controllable release of amorphous active ingredient for administration once per day
NO872259D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive trans-6(2-(3-eller 4-karboksamido-substituert pyrrol-1-yl)alkyl)-4-hydroksypyran-2-on-derivater.
MA21722A1 (fr) Derives de 2 - aminopyrimidinones utiles notamment comme antagonistes des neurotransmetteurs et procede pour leur preparation .
IE782070L (en) Azabicyclo (3.2.0) hept-2-ene carboxylic acid derivatives
DE19975059I2 (de) (2-Oxo-3-tetrahydrothienylcarbamoyl)-alkylthio-essigsäure, ihre Salze und Ester, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel.
IL95956A0 (en) Benzoic acid derivatives and pharmaceutical compositions containing the same
LV10917B (en) New use of bambuterol
AU3003189A (en) 7(2-(2-aminothiazol-4-yl)-2-hydroxyimino-acetamido)-3- methoxymethyl-3-cephem-4-carboxylate ester derivatives
ATE19236T1 (de) (omega-(diaethylamino)-alkoxy)-alpha-(aethyl)benzhydrolderivate, ihre saeureadditionssalze und quaternaeren salze, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
DE2964634D1 (en) 3,7-disubstituted-2- or -3-cephem-4-carboxylic acid compounds, pharmaceutical compositions containing them and processes for the preparation thereof
AU558261B2 (en) Dialkylaminoalkyoxybenzylalcohol derivatives
EP0831869B1 (en) Diphosphonate derivatives of therapeutic agents
AU663998B2 (en) Chondroprotective agents
ATE27270T1 (de) Thioester von acetylsalicylsaeure, ein verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
NO177484C (no) Fremgangsmåte for fremstilling av et farmasöytisk preparat i form av myke kapsler
CA2310318A1 (en) Pseudopolymorphic forms of 2-[2-[4-[bis (4-fluorophenyl) methyl]-1-piperazinyl] ethoxy]acetic acid dihydrochloride
ATE1855T1 (de) Antiarthritische hydroxyessigsaeurederivate, pharmazeutische zusammensetzungen daraus und verfahren zu ihrer herstellung.
AU5795594A (en) New N-benzylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them
IE41219L (en) Aralkyl esters of aminoalkanoic acids
JPH07507786A (ja) 脂肪酸，例えばｚ−ヒドロキシミスチン酸の抗ウイルス剤としての使用
AU588960B2 (en) New nitrogen-arylmethoxy-thiophene derivatives and acid addition salts thereof, processes for their preparation and pharmaceutical preparations containing these compounds
WO1987004435A3 (en) Xanthine compounds
IE800960L (en) Phenylthioethyl carboxylic acid hydrazides